QUODD

Insider Transactions last 24 months for Protalix BioTherapeutics, Inc. - AMEX: PLX

Transactions
All	Buy	Sell	Option Exercise

Filer's Name	Relationship/ Title	Trans. Date	Trans. Type	Ownership Type	Security Type	Shares	Price	Trans. Value	Total Shares Owned
Bashan Dror	PRESIDENT AND CEO	09/03/2025	AA	Indirect	COM	195,000	$0.00	$0.00	2,344,418
Naos Yaron	Sr. VP, Operations	09/03/2025	AA	Indirect	COM	25,000	$0.00	$0.00	225,817
Bar-Shalev Amos	Director	09/03/2025	AA	Indirect	COM	7,500	$0.00	$0.00	7,500
Ben Zvi Shmuel	Director	09/03/2025	AA	Indirect	COM	7,500	$0.00	$0.00	7,500
Schwartz Aharon	Director	09/03/2025	AA	Indirect	COM	7,500	$0.00	$0.00	7,500
Boudes Pol F	Director	09/03/2025	AA	Indirect	COM	7,500	$0.00	$0.00	7,500
Melincoff Gwen A	Director	09/03/2025	AA	Indirect	COM	7,500	$0.00	$0.00	7,500
Elze Christian	Director	09/03/2025	AA	Indirect	COM	7,500	$0.00	$0.00	7,500
Forster Eliot	Director	09/03/2025	AA	Indirect	COM	7,500	$0.00	$0.00	7,500
Schwartz Aharon	Director	06/10/2025	AP	Direct	COM	129,000	$1.60	$205,884.00	303,000
Rubin Eyal	Sr. VP and CFO	09/23/2024	AA	Indirect	COM	99,010	$0.00	$0.00	669,010
Bashan Dror	PRESIDENT AND CEO	04/01/2024	AA	Indirect	COM	263,960	$0.00	$0.00	2,149,418
Bashan Dror	PRESIDENT AND CEO	10/19/2023	AP	Direct	COM	16,129	$1.41	$22,741.89	132,516
Bashan Dror	PRESIDENT AND CEO	10/19/2023	AP	Direct	COM	48,387	$1.40	$67,741.80	116,387

1 You are at page 1 of 1 pages

Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security \| D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) \| E = Expiration of short derivative position \| F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. \| G = Gift \| H = Expiration (or cancellation) of long derivative position with value received \| I = Discretionary transaction in accordance with Rule 16b-3(f) \| J = Other \| L = Small acquisition under Rule 16a-6 \| M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 \| O = Exercise of out-of-the-money derivative security \| P = Open market or private purchase \| S = Open market or private sale \| U = Disposition pursuant to a tender of shares in a change of control transaction \| W = Acquisition or disposition by will or the laws of descent and distribution \| X = Exercise of in-the-money or at-the-money derivative security \| Z = Deposit into or withdrawal from voting trust		Send to Excel

Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust

Send to Excel